Molecular Devices and MIMETAS Webinar to Discuss Turnkey Solution for Organ-on-a-Chip Market

Share Article

In this webinar, which LabRoots will host March 7, participants will engage in discussions on a unique, easy-to-use organ-on-a-chip platform, compatible with automated high-content imaging.

Jos Joore, PhD Co-founder and Managing Director, MIMETAS

The recent progress in the development of 3D models and techniques over the past few years has been significant, including new methods for biodegradable scaffolds, organ-on-a chip structures, or self-assembled organoids. Recently, simple, easily automated workflows, suitable for high-content imaging have become popular.

MIMETAS OrganoPlates® are a novel microfluidic culture platform enabling long-term, membrane-free 3D co-culture models in a microtiter plate format. MIMETAS has developed a large variety of tissue- and disease models, applicable for drug testing and evaluation. The platform is compatible with standard readout equipment, like the ImageXpress® Micro Confocal High-Content Imaging System (Molecular Devices), and is suitable for high-throughput automation.

In this webinar, attendees will have the opportunity to learn more about organ-on-a-chip models in OrganoPlates®, using precise, barrier-free definition of culture matrices and cells in 3D. OrganoPlate® models support cell-cell interaction, unprecedented readouts and quantification. A discussion on this scalable and robust microfluidic platform, supporting up to 96 tissue models on a single plate, can also be expected.

Molecular Devices, who is sponsoring this webinar, has selected Dr. Jos Joore, co-founder and managing director of MIMETAS, to present.

Joore received both a Master’s in Biology and a Doctorate in Developmental Biology from Utrecht University in the Netherlands. He later earned a Master’s in Business Marketing from Eindhoven University of Technology. During his ten-year research career, he worked as a postdoctoral researcher at the Hubrecht Institute in Utrecht and King's College in London. He is a biotech entrepreneur, co-founder of 4 companies with over seventeen years of executive level biotech experience; in his current role he is the co-founder and managing director of MIMETAS.

LabRoots will host this webinar March 7, 2017, beginning at 7 a.m. PT, 10 a.m. ET and 3 p.m. GMT. To learn more about this event, read about the P.A.C.E. and Florida continuing education credits offered, or to register for free, click here.

Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables and is dedicated to helping customers unravel the complexity of biological systems. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These innovative instruments, combined with scientific expertise, assays, and analytics tools for protein and cell biology, enable scientists to explore life’s most important questions. The company is headquartered in Silicon Valley, California with offices around the globe. For more information, please visit:

MIMETAS (Leiden, The Netherlands) is a biotechnology company developing human organ-on-a-chip tissue models for testing drugs, chemicals and food components in OrganoPlates®. The company develops and validates customized disease, toxicology and transport models and ultimately will make its technology available for personalized therapy selection. Mimetas’ unique microfluidic technology and model development know-how enables testing of compounds in high-throughput, showing better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® culture platform supports 3D cell culture under continuous perfusion, with membrane-free co-culture and epithelial and endothelial tubules. For more information, visit

LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website